Life Sciences and Pharma IP Litigation 2025

AUSTRALIA Trends and Developments Contributed by: Ben Miller, Stephen Rohl, Katie Pryor and Jenny Wong, Maddocks

Katie Pryor is a senior associate in Maddocks’ IP team, with expertise in sectors including medtech, pharmaceuticals and engineering. With a degree in science (majoring in

Jenny Wong is an IP litigation senior associate at Maddocks with experience in complex multi-jurisdictional patent disputes involving clients in the life sciences and engineering

pharmacology), she has a particular focus on matters relating to highly complex technical subject matter. Katie has advised various multinational clients on IP commercialisation, transactions, enforcement and freedom to operate. She has acted in a number of global patent disputes, involving proceedings before the Federal Court of Australia, the High Court of Australia, the UK High Court and Court of Appeal, and the European Patent Office.

sectors. She has a PhD in biochemistry with specialist training in molecular biology. She specialises in life sciences patent cases before the Federal Court of Australia and has acted for clients in patent disputes relating to human vaccines, small molecules, biosimilar monoclonal antibodies, transgenic mice and gene editing technology. Jenny also advises clients on issues relating to freedom to operate and pricing, and reimbursement of prescription pharmaceutical products in Australia.

Maddocks Angel Place Level 27 123 Pitt Street Sydney NSW 2000 Australia Tel: +61 2 9291 6100

Email: info@maddocks.com.au Web: www.maddocks.com.au

10

CHAMBERS.COM

Powered by